...
首页> 外文期刊>Clinical transplantation. >Protective action of bone marrow mesenchymal stem cells in immune tolerance of allogeneic heart transplantation by regulating CD CD 45 RB RB + + dendritic cells
【24h】

Protective action of bone marrow mesenchymal stem cells in immune tolerance of allogeneic heart transplantation by regulating CD CD 45 RB RB + + dendritic cells

机译:骨髓间充质干细胞在调节CD 45 rb +树突细胞中对同种异体心脏移植免疫耐受的保护作用

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Background Bone marrow‐derived mesenchymal stem cells ( BMSC s) could exert a potent immunosuppressive effect and therefore may have a therapeutic potential in T‐cell‐dependent pathologies. We aimed to examine the effects of BMSC s on immune tolerance of allogeneic heart transplantation and the involvement of CD 45 RB + dendritic cells ( DC s). Methods Bone marrow‐derived DC s and BMSC s were co‐cultured, with CD 45 RB expression on the surface of DC s measured by flow cytometry. qRT ‐ PCR and Western blotting were used to detect mRNA and protein levels. Cytometric bead array was performed to determine the serum level of IL ‐10. Survival time of transplanted heart and expression of CD 4 + , CD 8 + , IL ‐2, IL ‐4, IL ‐10, IFN ‐γ were determined. Immunofluorescence assay was employed to determine intensity of C3d and C4d. Results DC s co‐cultured with BMSC s showed increased CD 45 RB and Foxp3 levels. CD 45 RB + DC s co‐cultured with T‐cells CD 4 + displayed increased T‐cell CD 4 + Foxp3 ratio and IL ‐10 than DC s. Both of them extended survival time of transplanted heart, decreased histopathological classification and score, intensity of C3d, C4d, proportion of CD 4 + , expression levels of IL ‐2 and IFN ‐γ, and increased the CD 4 + Foxp3 ratio and levels of IL ‐4 and IL ‐10. CD 45 RB + DC s achieved better protective effects than DC s. Conclusion BMSC s increased the expression of CD 45 RB in the bone marrow‐derived DC s, thereby strengthening immunosuppression capacity of T cells and immune tolerance of allogeneic heart transplantation.
机译:摘要背景骨髓衍生的间充质干细胞(BMSC S)可以发挥有效的免疫抑制效果,因此可以具有T细胞依赖性病理的治疗潜力。我们旨在检测BMSC S对同种异体心脏移植免疫耐受性的影响及CD 45 rb +树突细胞(DC S)的累及。方法采用流式细胞术测量的DC S表面上的CD 45 rb表达骨髓衍生的DC S和BMSC S。 QRT - PCR和Western印迹用于检测mRNA和蛋白质水平。进行细胞计数珠阵列以确定IL -10的血清水平。确定移植心脏的存活时间和CD 4 +,CD 8 +,IL -2,IL -4,IL -10,IFN-γ的表达。使用免疫荧光测定法测定C3D和C4D的强度。结果与BMSC S共同培养的DC S显示CD 45 rb和Foxp3水平增加。用T细胞CD 4 +与T细胞CD 4 +的CD 45RB + DC S共培养,T细胞CD 4 + FoxP3比和IL-10比DC S。它们都延长了移植心脏的生存时间,降低了组织病理学分类和得分,C3D的强度,C4D,CD 4 +的比例,IL-2和IFN-γ的表达水平,并增加了CD 4 + Foxp3的比例和水平IL -4和IL -10。 CD 45 rb + DC S比DC S所取得更好的保护作用。结论BMSC S在骨髓衍生的DC S中CD 45 RB的表达,从而强化T细胞免疫抑制能力和同种异体心脏移植的免疫耐受性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号